HuWel has developed the Quantiplus COVID-19 detection kit. It has RT-PCR capabilities and has CDSCO and ICMR clearance for manufacturing and commercialisation.
What pain-point does it solve?
Currently there is limited availability of diagnostic kits.
Who are the ideal users of our technology?
Hospitals and diagnostic centres
How does it solve the pain-point?
The kit design provides scope for confirmation of COVID-19 infection and in case of any mutation in particular region at least one
of the target will be detected and sample can be further analysed for clarification.
What makes us stand apart from competitors ?
Domestically manufactured and cheaper cost per test.
The story of our successful deployments
Received orders from Telegana State Govt.
If you have any queries, please don’t hesitate to get in touch.
We are looking forward to hearing from you.
